115.20
Davita Inc stock is traded at $115.20, with a volume of 767.23K.
It is down -1.17% in the last 24 hours and down -8.48% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$116.56
Open:
$116.89
24h Volume:
767.23K
Relative Volume:
0.95
Market Cap:
$8.24B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
10.73
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-6.80%
1M Performance:
-8.48%
6M Performance:
-20.53%
1Y Performance:
-26.61%
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
115.20 | 8.23B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
481.06 | 109.11B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
194.25 | 16.96B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 13.30B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
227.94 | 14.30B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
111.92 | 11.34B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
What catalysts could drive DaVita Inc. stock higherMarket Growth Summary & Community Consensus Trade Signals - newser.com
Will DaVita Inc. stock outperform international peers2025 Performance Recap & High Accuracy Trade Alerts - newser.com
How DaVita Inc. (TRL) stock expands through international marketsJuly 2025 Action & Pattern Based Trade Signal System - newser.com
Published on: 2025-11-19 10:52:21 - newser.com
Is DaVita Inc. (TRL) stock testing key supportTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Davita Healthcare stock hits 52-week low at $114.81 By Investing.com - Investing.com Canada
How forex fluctuations impact DaVita Inc. stockAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
How DaVita Inc. (TRL) stock moves on employment data2025 Institutional Moves & Weekly Top Performers Watchlists - newser.com
Has DaVita Inc. formed a bullish divergence2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
How DaVita Inc. stock trades pre earnings2025 Sector Review & Community Consensus Trade Alerts - newser.com
Why DaVita Inc. stock stays on buy listsEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Why DaVita Inc. (TRL) stock is trending on social mediaJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - newser.com
Will DaVita Inc. (TRL) stock deliver compounding returns2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
What hedge fund moves indicate for DaVita Inc. stockChart Signals & Daily Entry Point Alerts - newser.com
Will DaVita Inc. stock profit from fiscal stimulusJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Will DaVita Inc. rebound enough to break evenJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Technical analysis overview for DaVita Inc. stock2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
DaVita at Wolfe Conference: Navigating Challenges and Growth - Investing.com
Using AI based signals to follow DaVita Inc.Bond Market & Weekly Momentum Stock Picks - newser.com
Is a relief rally coming for DaVita Inc. holders2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Sentiment analysis tools applied to DaVita Inc.July 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):